Regulation of latent stage differentiation through central carbon metabolism and ubiquitination
Regulation of latent stage differentiation through central carbon metabolism and ubiquitination
批准号:
10563243
负责人:
Chris Tonkin
金额:
$52.2万
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
未结题
起止时间:
2022-12-05 至 2027-11-30
关键词:
AcuteAmino AcidsBiochemicalBiologyBlindnessBrainCRISPR screenCarbonCentral Nervous SystemClinicalComplexCountryCuesDevelopmentDiseaseDrug resistanceEnvironmentEnzymesExposure toGenesGeneticGenetic ScreeningGenetic TranscriptionGlutamineHumanImmunocompromised HostIn VitroIndividualLifeLinkMetabolicMetabolic PathwayMetabolismMethodologyMuscleNutritionalParasitesPathogenesisPatientsPharmaceutical PreparationsPlayPopulationPrevalenceProteomicsPublishingRefractoryRegulationRoleSignal TransductionSourceStructureTechniquesTissuesToxoplasmaTranslationsUbiquitinUbiquitinationWorkbrain tissuegenome-widein vivoinsightlatent infectionmetabolomicsmodel organismprogramstherapy resistantubiquitin-protein ligasewhole genome
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Project summary
Toxoplasma latently infects approximately 30% of the human population and is refractory to acute stage
therapies. Latent Toxoplasma can act as a reservoir for acute stage reactivation in immunocompromised
individuals and can cause progressive blindness in otherwise healthy individuals. Thus, latent stages are
clinically important, but currently untreatable.
Drug resistance is likely due to changes in the metabolism of latent stages, but what these are remain a complete
mystery. Furthermore, latent Toxoplasma is exposed to different nutritional environments when infecting its
target tissue types – muscle and the central nervous system (CNS) – and the impact this has on Toxoplasma
latency is not understood. We have found that changes in carbon sources, that mimic muscle and CNS trigger
Toxoplasma differentiation into latent forms. We then performed a whole-genome CRISPR screen and identified
select Toxoplasma carbon catabolic enzymes that are required for differentiation and furthermore, identified a
role for ubiquitination in metabolic adaptation and differentiation into latent forms.
These background studies form the basis for developing a comprehensive understanding of Toxoplasma
metabolism during latency and understanding how metabolic rewiring is linked to differentiation through
regulation by ubiquitination. The specific aims of this program are to:
Aim 1: Define the metabolic pathways required for differentiation and persistence of latent Toxoplasma.
We will determine the role of select enzymes (identified in CRISPR screen) required for utilization of carbon
sources that mimic brain and muscle and their impact on differentiation in vitro and in vivo. This will determine
how metabolism of latent and acute stages differs and how this is linked to environmental sensing and
differentiation.
Aim 2: Determine the role of ubiquitination in the regulation of differentiation into latent forms. Define the
composition, biochemical activity and structure of an E3 ubiquitin ligase complex that is important for
differentiation into latent forms, thus determining how ubiquitination regulates differentiation.
Aim 3: Define how ubiquitination regulates metabolism and differentiation into latent forms. We have
identified likely substrates of the E3 ubiquitination machinery and will define their function in regulation of both
metabolism and differentiation.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
海外基金